BetterLife Pharma Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Public

  • Employees
  • 4

Employees

  • Stock Symbol
  • BETR

Stock Symbol

  • Investments
  • 10

  • Share Price
  • $0.15
  • (As of Tuesday Closing)

BetterLife Pharma General Information

Description

BetterLife Pharma Inc is an emerging biotechnology company focused on developing and commercializing the compound BETR-001 to treat neuropsychiatric and neurological disorders. BETR-001 is a non-hallucinogenic and non-controlled LSD derivative in development, and it is unregulated and therefore can be self-administered. BetterLife's synthesis patent for BETR-001 eliminates regulatory hurdles, and its pending patent for composition and method of use covers treatment of depression, cluster headaches, post-traumatic stress disorder, and other neuropsychiatric and neurological disorders.

Contact Information

Formerly Known As
Neurokine Pharmaceuticals, Pivot Pharmaceuticals
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 1275 West 6th Avenue
  • Suite 300
  • Vancouver, British Columbia V6H 1A6
  • Canada
+1 (604)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Stock Exchange
CNQ
Vertical(s)
Corporate Office
  • 1275 West 6th Avenue
  • Suite 300
  • Vancouver, British Columbia V6H 1A6
  • Canada
+1 (604)

BetterLife Pharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BetterLife Pharma Stock Performance

As of 17-Nov-2026, BetterLife Pharma’s stock price is $0.15. Its current market cap is $95.7M with 651M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.15 $0.14 $0.03 - $0.33 $95.7M 651M 423K -$0.02

BetterLife Pharma Financials Summary

As of 31-Jul-2026, BetterLife Pharma has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 31-Jul-2026 FY 2026 31-Jan-2026 FY 2025 31-Jan-2025 FY 2024 31-Jan-2024
EV 36,805 8,839 14,772 10,047
Revenue 0 0 0 0
EBITDA (2,383) (920) (2,393) (2,109)
Net Income (2,513) (1,074) (2,551) (2,139)
Total Assets 1,460 161 155 242
Total Debt 2,094 899 898 1,096
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BetterLife Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BetterLife Pharma‘s full profile, request access.

Request a free trial

BetterLife Pharma Patents

BetterLife Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023039682-A1 Lsd derivatives, synthesis & method for treatment of diseases and disorders Inactive 20-Sep-2021
WO-2022221942-A1 Prevention of drug diversion Inactive 19-Apr-2021
WO-2022198315-A1 Methods of treating mental and/or mood disorders using 2-bromo-lsd alone or in combination with a mtor inhibitor Inactive 22-Mar-2021
WO-2022160065-A1 Formulations including dihydrohonokiol Inactive 31-Jan-2021
WO-2022133604-A1 Methods of treating mental or mood disorders using 2-bromo-lsd Inactive 22-Dec-2020 A61P25/24
To view BetterLife Pharma’s complete patent history, request access »

BetterLife Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BetterLife Pharma Investments & Acquisitions (10)

BetterLife Pharma’s most recent deal was a Merger/Acquisition with Transcend Biodynamics for . The deal was made on 18-Dec-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Transcend Biodynamics 18-Dec-2020 Merger/Acquisition Biotechnology
Altum Pharmaceuticals 31-Aug-2020 Merger/Acquisition Biotechnology
iAmHealth Distribution 01-Dec-2019 Merger/Acquisition Specialty Retail
Solmic (Switzerland) 22-Oct-2019 Merger/Acquisition Biotechnology
Pivot-Cartagena Joint Venture 19-Dec-2018 Joint Venture Beverages
You’re viewing 5 of 10 investments and acquisitions. Get the full list »

BetterLife Pharma ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view BetterLife Pharma’s complete esg history, request access »

BetterLife Pharma Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Indus Pharma Karachi, Pakistan 1969

BetterLife Pharma FAQs

  • When was BetterLife Pharma founded?

    BetterLife Pharma was founded in 2002.

  • Where is BetterLife Pharma headquartered?

    BetterLife Pharma is headquartered in Vancouver, Canada.

  • What is the size of BetterLife Pharma?

    BetterLife Pharma has 4 total employees.

  • What industry is BetterLife Pharma in?

    BetterLife Pharma’s primary industry is Drug Discovery.

  • Is BetterLife Pharma a private or public company?

    BetterLife Pharma is a Public company.

  • What is BetterLife Pharma’s stock symbol?

    The ticker symbol for BetterLife Pharma is BETR.

  • What is the current stock price of BetterLife Pharma?

    As of 17-Nov-2026 the stock price of BetterLife Pharma is $0.15.

  • What is the current market cap of BetterLife Pharma?

    The current market capitalization of BetterLife Pharma is $95.7M.

  • What is BetterLife Pharma’s annual earnings per share (EPS)?

    BetterLife Pharma’s EPS for 12 months was -$0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process